Serious adverse events or adverse events Death due to methadone use · individuals dependent on illicit opiates
1 finding from 1 review
Retention in treatment · individuals dependent on illicit opiates
Dihydrocodeine showed no clear difference in treatment retention compared with methadone (low certainty).
1 finding from 1 review
Intervention not reported
WORK PARTICIPATION · People with non‐specific low back pain presenting to healthcare, occupational, general or mixed populations Prognostic factor: Individual…
The intervention probably leads to higher WORK PARTICIPATION (moderate certainty).
1 finding from 1 review
Intervention not reported
IMPORTANT RECOVERY · People with non‐specific low back pain presenting to healthcare, occupational, general or mixed populations Prognostic factor: Individual…
The intervention may leads to higher IMPORTANT RECOVERY (low certainty).
1 finding from 1 review
Intervention not reported
FUNCTIONAL LIMITATIONS · People with non‐specific low back pain presenting to healthcare, occupational, general or mixed populations Prognostic factor: Individual…
It is very uncertain whether the intervention changes FUNCTIONAL LIMITATIONS (very low certainty).
1 finding from 1 review
Intervention not reported
PAIN INTENSITY · People with non‐specific low back pain presenting to healthcare, occupational, general or mixed populations Prognostic factor: Individual…
The intervention may leads to higher PAIN INTENSITY (low certainty).
1 finding from 1 review
Intervention not reported
Test result · HIV‐positive individuals
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
True positives (participants correctly classified as having tuberculosis) · HIV‐positive individuals
1 finding from 1 review
no estimate extracted
368 participants
Very low
Intervention not reported
False negatives (participants incorrectly classified as not having tuberculosis) · HIV‐positive individuals
1 finding from 1 review
no estimate extracted
368 participants
Very low
Intervention not reported
True negatives (participants correctly classified as not having tuberculosis) · HIV‐positive individuals
1 finding from 1 review
no estimate extracted
511 participants
Very low
Intervention not reported
False positives (participants incorrectly classified as having tuberculosis) · HIV‐positive individuals
1 finding from 1 review
no estimate extracted
511 participants
Very low
Intervention not reported
Virological success · antiretroviral‐naïve individuals
The intervention showed no clear difference in virological success (high certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: pyrexia · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: pyrexia (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised transaminases · antiretroviral‐naïve individuals
The intervention leads to lower severe adverse events: raised transaminases (high certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised alkaline phosphatase · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: raised alkaline phosphatase (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised amylase · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: raised amylase (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised triglycerides · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: raised triglycerides (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: neutropenia · antiretroviral‐naïve individuals
The intervention leads to lower severe adverse events: neutropenia (high certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: rash · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: rash (moderate certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: serum glutamic oxaloacetic transaminase (SGOT) · antiretroviral‐naïve individuals
1 finding from 1 review